Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

A majority of patients with type 1 diabetes who were treated with dapagliflozin, a type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology. …read more

Source: EurekAlert

(Visited 4 times, 1 visits today)

Popular Posts